Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Osmancik, Pavel ^a   Teringova, Elena ^a   Tousek, Petr ^a   Paulu, Petra ^a   Widimsky, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; FAS ANTIGEN; SOLUBLE FAS ANTIGEN; TROPONIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; AGE; AGED; APOPTOSIS; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; ROC CURVE; STROKE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84874158796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053860     Document Type: Article

References (32)

1. Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, et al. (2003) Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 41: 753-60.
2. Wiley SR, (1995) Schooley K, Smolak PJ, Din WS, Huang CP, et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-82.
3. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, et al. (1997) TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7: 831-6.
4. Mueller M, Celik S, Biener M, Vafaie M, Schwoebel K, et al. (2012) Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol 101: 837-45.
5. Guidez T, Marechaux S, Pincon C, Lamour H, Barrailler S, et al. (2012) Addition of B-type natriuretic peptide to the GRACE score to predict outcome in acute coronary syndrome: a retrospective (development) and prospective (validation) cohort-based study. Emerg Med J 29: 274-9.
6. Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, et al. (2009) Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J 30: 789-96.
7. Volpato S, Ferrucci L, Secchiero P, Corallini F, Zuliani G, et al. (2011) Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. Atherosclerosis 215: 452-8.
8. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, et al. (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29: 2909-45.
9. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, et al. (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32: 2999-3054.
10. Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, et al. (2010) Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol 55: 2435-45.
11. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ, (2001) More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3: 315-22.
12. Rossig L, Fichtlscherer S, Heeschen C, Berger J, Dimmeler S, et al. (2004) The pro-apoptotic serum activity is an independent mortality predictor of patients with heart failure. Eur Heart J 25: 1620-5.
13. Goussev A, Sharov VG, Shimoyama H, Tanimura M, Lesch M, et al. (1998) Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 275: H626-31.
14. Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, et al. (2002) Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 106: 2967-72.
15. Jayasankar V, Woo YJ, Pirolli TJ, Bish LT, Berry MF, et al. (2005) Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J Card Surg 20: 93-101.
16. Filippatos G, Uhal BD, (2003) Blockade of apoptosis by ACE inhibitors and angiotensin receptor antagonists. Curr Pharm Des 9: 707-14.
17. Landmesser U, Drexler H, (2005) Chronic heart failure: an overview of conventional treatment versus novel approaches. Nat Clin Pract Cardiovasc Med 2: 628-38.
18. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, et al. (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611-20.
19. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, et al. (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12: 599-609.
20. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-63.
21. Li JH, Kirkiles-Smith NC, McNiff JM, Pober JS, (2003) TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells. J Immunol 171: 1526-33.
22. Zauli G, Pandolfi A, Gonelli A, Di Pietro R, Guarnieri S, et al. (2003) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. Circ Res 92: 732-40.
23. Secchiero P, Corallini F, di Iasio MG, Gonelli A, Barbarotto E, et al. (2005) TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Blood 105: 3413-9.
24. Toffoli B, Bernardi S, Candido R, Zacchigna S, Fabris B, et al. (2012) TRAIL shows potential cardioprotective activity. Invest New Drugs.
25. Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, et al. (2005) The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol 45: 1018-24.
26. Secchiero P, Corallini F, Ceconi C, Parrinello G, Volpato S, et al. (2009) Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction. PLoS One 4: e4442.
27. Secchiero P, Corallini F, Beltrami AP, Ceconi C, Bonasia V, et al. (2010) An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. Atherosclerosis 210: 274-7.
28. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL, (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-8.
29. Dorn GW, 2nd (2009) Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81: 465-73.
30. Zhao L, Wang L, Zhang Y, (2009) Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. J Invasive Cardiol 21: 493-8.
31. Byrne RA, Ndrepepa G, Braun S, Tiroch K, Mehilli J, et al. (2010) Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 106: 1212-7.
32. Oemrawsingh RM, Lenderink T, Akkerhuis KM, Heeschen C, Baldus S, et al. (2011) Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome. Heart 97: 1061-6.